CEB Inc (CEB) Drops 5.02% on January 13

Equities Staff |

CEB Inc (CEB) was one of the Russell 2000's biggest losers for Wednesday January 13 as the stock slid 5.02% to $54.54, a loss of $-2.88 per share. Starting at an opening price of $57.54 a share, the stock traded between $53.92 and $57.55 over the course of the trading day. Volume was 91,975 shares over 1,079 trades, against an average daily volume of 182,080 shares and a total float of 33.09 million.

The losses send CEB Inc down to a market cap of $1.8 billion. In the last year, CEB Inc has traded between $91.57 and $55.68, and its 50-day SMA is currently $68.10 and 200-day SMA is $76.26.

The stock has a P/E Ratio of 18.9.

CEB Inc is a member-based advisory company. It provides historical fixed-fee annual subscription model for membership programs, and technology-enabled subscription and engagement-based talent assessment and management services.

CEB Inc is based out of Arlington, VA and has some 4,300 employees. Its CEO is Thomas L. Monahan.

For a complete fundamental analysis analysis of CEB Inc, check out’s Stock Valuation Analysis report for CEB. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Pressure Biosciences Inc

Pressure BioSciences Inc is a biological life sciences research company. It is engaged in the development and commercialization of a platform technology called pressure cycling technology.

Private Markets

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…


The spark hit Jamie when he saw co-workers competing to lose weight. Instead of pizzas and subs, they were eating salads and jogging along the river. Some were sneakily leaving…